Insider Transactions in Q3 2023 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.35%
|
$502,500
$67.62 P/Share
|
|
Aug 31
2023
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
2,708
-10.29%
|
$178,728
$66.52 P/Share
|
|
Aug 31
2023
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,480
+9.81%
|
$109,600
$20.84 P/Share
|
|
Aug 29
2023
|
David Weill |
BUY
Open market or private purchase
|
Direct |
2,500
+15.44%
|
$155,000
$62.0 P/Share
|
|
Aug 01
2023
|
Anil P. Ranganath |
BUY
Grant, award, or other acquisition
|
Direct |
9,512
+50.0%
|
-
|
|
Aug 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.46%
|
$690,000
$92.86 P/Share
|
|
Jul 18
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.81%
|
$475,000
$95.37 P/Share
|
|
Jul 18
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.75%
|
$135,000
$27.3 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Indirect |
2,225
-13.09%
|
$200,250
$90.02 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,974
-17.14%
|
$267,660
$90.05 P/Share
|
|
Jul 13
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,974
+14.63%
|
$47,584
$16.14 P/Share
|
|
Jul 03
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.45%
|
$615,000
$82.67 P/Share
|